These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2393411)

  • 1. DNA damage and sequence specificity of DNA binding of the new anti-cancer agent 1,4-bis(2'-chloroethyl)-1,4-diazabicyclo-[2.2.1] heptane dimaleate (Dabis maleate).
    Broggini M; Hartley JA; Mattes WB; Ponti M; Kohn KW; D'Incalci M
    Br J Cancer; 1990 Feb; 61(2):285-9. PubMed ID: 2393411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a prospective antitumor agent, 1,4-bis(2'-chloroethyl)-1,4-diazabicyclo-[2.2.1] heptane diperchlorate, on cultured mammalian cells.
    Traganos F; Darzynkiewicz Z; Bueti C; Melamed MR
    Cancer Invest; 1984; 2(1):1-13. PubMed ID: 6584191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of 1,4-bis (2'-chloroethyl)-1,4-diazabicyclo-[2.2.1] heptane dimaleate (Dabis Maleate) in M5076 and its subline resistant to cyclophosphamide M5/CTX.
    Tagliabue G; Filippeschi S; Hendricks H; D'Incalci M
    Ann Oncol; 1992 Mar; 3(3):233-6. PubMed ID: 1586622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent administration of Dabis Maleate, a phase I study.
    Verweij J; Planting AS; de Boer M; van der Burg ME; Stoter G
    Ann Oncol; 1992 Mar; 3(3):241-2. PubMed ID: 1586625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of a benzoic acid mustard derivative of distamycin A (FCE 24517) and related minor groove-binding distamycin analogues on the activity of major groove-binding alkylating agents.
    Coley HM; Mongelli N; D'Incalci M
    Biochem Pharmacol; 1993 Feb; 45(3):619-26. PubMed ID: 8442762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic analysis of drug-induced G2 block in vitro.
    Kimmel M; Traganos F
    Cell Tissue Kinet; 1985 Jan; 18(1):91-110. PubMed ID: 3918795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I study of DABIS maleate given once every 3 weeks.
    van der Burg ME; Planting AS; Stoter G; McDaniel C; Vecht CJ; Verweij J
    Eur J Cancer; 1991; 27(12):1635-7. PubMed ID: 1782074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineoplastic agents LXIV: 1,4-Bis(2'-chloroethyl)-1,4-diazabicyclo[2.2.1]heptane dihydrogen dimaleate.
    Pettit GR; Gieschen DP; Pettit WE
    J Pharm Sci; 1979 Dec; 68(12):1539-42. PubMed ID: 529047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro pharmacokinetics and pharmacodynamics of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU).
    Ueda-Kawamitsu H; Lawson TA; Gwilt PR
    Biochem Pharmacol; 2002 Apr; 63(7):1209-18. PubMed ID: 11960597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective DNA interaction of the novel distamycin derivative FCE 24517.
    Broggini M; Erba E; Ponti M; Ballinari D; Geroni C; Spreafico F; D'Incalci M
    Cancer Res; 1991 Jan; 51(1):199-204. PubMed ID: 1859575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA breaks and repair in the mouse leukemia L1210 cells exposed to three different types of interstrand DNA cross-linkers.
    Yajima N; Hochi S; Miyata N; Kishi T; Kawanishi G
    Mutat Res; 1990 Jul; 236(1):43-50. PubMed ID: 2114540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of mitomycin C with mammalian DNA detected by alkaline elution.
    Dorr RT; Bowden GT; Alberts DS; Liddil JD
    Cancer Res; 1985 Aug; 45(8):3510-6. PubMed ID: 3926301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triptycenes: a novel synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, induce DNA cleavage and decrease the viability of leukemic cells in the nanomolar range in vitro.
    Perchellet EM; Magill MJ; Huang X; Brantis CE; Hua DH; Perchellet JP
    Anticancer Drugs; 1999 Sep; 10(8):749-66. PubMed ID: 10573208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro evaluation of the alkylating agent carmethizole.
    Elliott WL; Fry DW; Anderson WK; Nelson JM; Hook KE; Hawkins PA; Leopold WR
    Cancer Res; 1991 Sep; 51(17):4581-7. PubMed ID: 1873802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo DNA cross-linking by cyclophosphamide: comparison of human chronic lymphatic leukemia cells with mouse L1210 leukemia and normal bone marrow cells.
    DeNeve W; Valeriote F; Edelstein M; Everett C; Bischoff M
    Cancer Res; 1989 Jul; 49(13):3452-6. PubMed ID: 2731167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxicity and DNA damage caused by the azoxy metabolites of procarbazine in L1210 tumor cells.
    Erikson JM; Tweedie DJ; Ducore JM; Prough RA
    Cancer Res; 1989 Jan; 49(1):127-33. PubMed ID: 2908840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the mechanism of action of busulfan with hepsulfam, a new antileukemic agent, in the L1210 cell line.
    Pacheco DY; Stratton NK; Gibson NW
    Cancer Res; 1989 Sep; 49(18):5108-10. PubMed ID: 2766282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ecteinascidin 743 induces protein-linked DNA breaks in human colon carcinoma HCT116 cells and is cytotoxic independently of topoisomerase I expression.
    Takebayashi Y; Goldwasser F; Urasaki Y; Kohlhagen G; Pommier Y
    Clin Cancer Res; 2001 Jan; 7(1):185-91. PubMed ID: 11205907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reaction of N-(2-chloroethyl)-N-nitrosoureas with DNA: effect of buffers on DNA adduction, cross-linking, and cytotoxicity.
    Chen FX; Bodell WJ; Liang G; Gold B
    Chem Res Toxicol; 1996; 9(1):208-14. PubMed ID: 8924592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the antitumor agent 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one on the DNA of mouse L1210 cells.
    Gibson NW; Erickson LC; Hickman JA
    Cancer Res; 1984 May; 44(5):1767-71. PubMed ID: 6713380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.